Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: q


Summaries of Product Characteristics 1 - 25 of 25
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Qarziba - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
QINLOCK - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Qlaira tabletti, kalvopäällysteinen SPC 2022-01-31

PL

Resepti

Qsiva 3.75 mg-23 mg, 7.5 mg-46 mg, 11.25 mg-69 mg, 15 mg-92 mg säädellysti vapauttava kapseli, kova SPC 2022-05-31

European Medicines Agency's website:
Qtern - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Qtern - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Quadramet - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Questran 4 g jauhe oraalisuspensiota varten SPC 2022-02-03

PL

Resepti

Quetiapin Hexal 50 mg, 150 mg, 200 mg, 300 mg, 400 mg depottabletti SPC 2021-06-22

PL

Resepti

Quetiapin Krka 50 mg, 200 mg, 300 mg, 400 mg depottabletti SPC 2021-12-10

PL

Resepti

Quetiapin Medical Valley 50 mg, 150 mg, 200 mg, 300 mg, 400 mg depottabletti SPC 2022-02-07

PL

Resepti

Quetiapin Orion 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen SPC 2021-12-23

PL

Resepti

Quetiapin ratiopharm 50 mg, 200 mg, 300 mg, 400 mg depottabletti SPC 2022-05-23

Resepti

Quetiapine Accord 150 mg depottabletti SPC 2021-07-01.doc

PL

Resepti

Quetiapine Accord 150 mg depottabletti SPC 2022-07-21 Uusi

PL

Resepti

Quetiapine Accord 200 mg, 300 mg, 400 mg depottabletti SPC 2022-07-21 Uusi

Resepti

Quetiapine Accord 200, 300, 400 mg depottabletti SPC 2021-07-01.docx

PL

Resepti

Quetiapine Accord 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen SPC 2022-03-18

Resepti

Quetiapine Accord 50 mg depottabletti SPC 2021-07-01.doc

PL

Resepti

Quetiapine Accord 50 mg depottabletti SPC 2022-07-21 Uusi

PL

Resepti

Quetiapine Teva 25 mg, 100 mg, 200 mg, 300 mg tabletti, kalvopäällysteinen SPC 2022-05-09

European Medicines Agency's website:
Quinsair - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Quofenix - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Qutenza - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Quviviq - EMA: EPAR PI
Finnish Swedish